지노타이핑 시장 규모, 점유율, 성장 분석 : 제품별, 기술별, 용도별, 최종 용도별, 지역별 - 산업 예측(2025-2032년)

Genotyping Market size was valued at USD 16.3 billion in 2023 and is poised to grow from USD 18.29 billion in 2024 to USD 45.93 billion by 2032, growing at a CAGR of 12.2% during the forecast period (2025-2032).

The global genotyping market is witnessing significant growth propelled by innovations in genomics, personalized medicine, and heightened demand for genetic testing services. This expansion is primarily driven by the rising incidence of genetic disorders, increasing public awareness regarding early disease detection, and advancements in precision medicine. Widely utilized technologies such as microarrays, polymerase chain reaction (PCR), and next-generation sequencing (NGS) are essential for both research and clinical applications. Furthermore, the integration of genotyping data with bioinformatics and analytics tools is further catalyzing market growth. As competition intensifies, leading industry players are prioritizing product innovation, broadening their genetic testing offerings, and forming strategic alliances to enhance their market position in the burgeoning global genotyping landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Genotyping market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Genotyping Market Segments Analysis

Global Genotyping Market is segmented by Product, Technology, Application, End-use and region. Based on Product, the market is segmented into Instruments, Reagents & Kits and Software and Services. Based on Technology, the market is segmented into PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry and Others. Based on Application, the market is segmented into Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics and Others. Based on End-use, the market is segmented into Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Genotyping Market

A significant factor propelling the global genotyping market is the heightened occurrence of genetic disorders alongside the escalating need for personalized medicine. Genotyping is essential in detecting genetic variations, mutations, and specific gene sequences linked to particular diseases and responses to medications. Recent advancements in genomic research and improved insights into genetic markers empower tailored diagnosis, treatment options, and drug selection. As the incidence of genetic disorders rises and there is a progressive shift towards precision medicine, the demand for innovative genotyping technologies and services continues to grow, further driving the market's expansion and relevance.

Restraints in the Genotyping Market

A major limitation in the global genotyping market pertains to the ethical and privacy issues surrounding genetic testing. The ability to access personal genetic data brings forth worries regarding potential misuse or misinterpretation of this sensitive information. Issues related to informed consent, data protection, and the risk of discrimination based on genetic insights create obstacles to the broader acceptance of genotyping. Furthermore, the proper interpretation and communication of genetic test results to both individuals and healthcare providers necessitate thoughtful approaches to ensure accurate understanding and appropriate follow-up actions. Effectively addressing these ethical and privacy challenges is essential for fostering trust, encouraging participation, and ensuring the responsible application of genotyping technologies.

Market Trends of the Genotyping Market

The global genotyping market is witnessing a significant trend towards personalized medicine and precision healthcare, fueled by an increasing demand for customized treatment solutions. As advancements in genomic technologies and the plummeting costs of genotyping enhance accessibility for healthcare providers and researchers, the capability to uncover genetic variations linked to diseases and drug responses becomes paramount. This enables the development of tailored treatment plans that optimize patient outcomes through targeted therapies and improved disease management. The growing awareness of the genetic underpinnings of various conditions is accelerating this trend, positioning genotyping as a cornerstone of modern healthcare innovations aimed at individualized patient care.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Analysis

Global Genotyping Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Reagents & Kits
• Software and Services

Global Genotyping Market Size by Technology & CAGR (2025-2032)

• Market Overview
• PCR
• Capillary Electrophoresis
• Microarrays
• Sequencing
• Mass Spectrometry
• Others

Global Genotyping Market Size by Application & CAGR (2025-2032)

• Market Overview
• Pharmacogenomics
• Diagnostics and Personalized Medicine
• Agricultural Biotechnology
• Animal Genetics
• Others

Global Genotyping Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Pharmaceutical and Biopharmaceutical Companies
• Diagnostics and Research Laboratories
• Academic Institutes
• Others

Global Genotyping Market Size & CAGR (2025-2032)

• North America (Product, Technology, Application, End-use)
  • US
  • Canada
• Europe (Product, Technology, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations